A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects ≥60 Years of Age

Update Il y a 5 ans
Reference: EUCTR2007-000343-10

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of the study is to evaluate the general safety of ZOSTAVAX™ in subjects ≥60 years of age.


Inclusion criteria

  • Herpes Zoster